Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Xoma completes direct public offering

    Xoma Corp. (NASDAQ:XOMA), Berkeley, Calif. Business: Antibodies, Endocrine/Metabolic, Autoimmune Date completed: 2014-12-09 Type: Direct public offering Raised: $40 million Shares: 8.1 million Price: $4.94 Shares after …

    Published on 12/15/2014
  • ANI Pharmaceuticals financial update

    ANI Pharmaceuticals Inc. (NASDAQ:ANIP), Baudette, Minn. Business: Generics Date announced: 2014-12-10 Note: ANI raised $18.8 million through the sale of senior convertible notes following the exercise by underwriters of…

    Published on 12/15/2014
  • Cortendo financial update

    Cortendo AB, Gothenburg, Sweden Business: Endocrine/Metabolic Date announced: 2014-12-05 Note: Cortendo terminated its plans to list on Oslo Stock Exchanges Oslo Axess market.

    Published on 12/15/2014
  • Trevena financial update

    Trevena Inc. (NASDAQ:TRVN), King of Prussia, Pa. Business: Cardiovascular, Neurology, Autoimmune Date announced: 2014-12-10 Note: Trevena raised $6.4 million through the sale of 1.6 million shares at $4 to cover the …

    Published on 12/15/2014
  • Versant financial update

    Versant Ventures, San Francisco, Calif. Business: Finance Date announced: 2014-12-10 Note: Versant Ventures closed its fifth fund with $305 million. It plans to invest Versant Venture Capital V in about 20-25 companies,…

    Published on 12/15/2014
  • VistaGen withdraws private placement of common stock and warrants

    VistaGen Therapeutics Inc. (OTCQB:VSTA), South San Francisco, Calif. Business: ADMET, Gene/Cell therapy, Neurology Date announced: 2014-12-05 Type: Private placement of common stock and warrants Note: VistaGen withdrew …

    Published on 12/15/2014
  • S1 Biopharma amends IPO

    S1 Biopharma Inc., New York, N.Y. Business: Genitourinary Date announced: 2014-11-26 Type: IPO To be raised: Up to $24.5 million Shares: 1.8 million Price: $12-$14 Underwriters: MLV; Northland Securities Inc. …

    Published on 12/8/2014
  • Syndax amends IPO

    Syndax Pharmaceuticals Inc., Waltham, Mass. Business: Cancer Date announced: 2014-11-21 Type: IPO To be raised: Up to $74.2 million Shares: TBD Price: TBD Underwriters: Deutsche Bank; Jefferies; JMP Securities; Wedbush …

    Published on 12/8/2014
  • Abeona completes venture financing

    Abeona Therapeutics Inc., Cleveland, Ohio Business: Endocrine/Metabolic Date completed: 2014-12-01 Type: Venture financing Raised: $3.6 million Investors: Cure Sanfilippo Foundation; Sanfilippo Research Foundation; Team…

    Published on 12/8/2014
  • Aethlon Medical completes private placement of units

    Aethlon Medical Inc. (OTCQB:AEMD), San Diego, Calif. Business: Infectious, Cancer Date completed: 2014-12-02 Type: Private placement of units Raised: $3.3 million Units: 11 million Price: $0.30 (unit) Shares after …

    Published on 12/8/2014
  • Allena Pharmaceuticals completes venture financing

    Allena Pharmaceuticals Inc., Newton, Mass. Business: Endocrine/Metabolic Date completed: 2014-12-04 Type: Venture financing Raised: $25 million Investors: HBM BioCapital; Frazier Healthcare; Third Rock Ventures; …

    Published on 12/8/2014
  • ANI Pharmaceuticals completes private placement of senior convertible notes

    ANI Pharmaceuticals Inc. (NASDAQ:ANIP), Baudette, Minn. Business: Generics Date completed: 2014-12-05 Type: Private placement of senior convertible notes Raised: $125 million Shares outstanding prior: 11.3 million …

    Published on 12/8/2014
  • Apellis completes venture financing

    Apellis Pharmaceuticals Inc., Crestwood, Ky. Business: Inflammation Date completed: 2014-12-02 Type: Venture financing Raised: $33 million Investors: Morningside Venture Investments; AJU IB Investment; Epidarex Capital

    Published on 12/8/2014
  • Ascendis completes venture financing

    Ascendis Pharma A/S, Hellerup, Denmark Business: Drug delivery Date completed: 2014-12-01 Type: Venture financing Raised: $60 million Investors: Sofinnova Ventures; OrbiMed Advisors; Vivo Capital; Janus Capital; Venrock…

    Published on 12/8/2014
  • Audentes Therapeutics completes venture financing

    Audentes Therapeutics Inc., San Francisco, Calif. Business: Musculoskeletal, Endocrine/Metabolic, Gene/Cell therapy Date completed: 2014-12-02 Type: Venture financing Raised: $42.5 million Investors: Deerfield …

    Published on 12/8/2014
  • Bellus Health completes private placement of notes

    Bellus Health Inc. (TSX:BLU), Laval, Quebec Business: Neurology, Endocrine/Metabolic Date completed: 2014-11-26 Type: Private placement of notes Raised: C$5.3 million ($4.7 million) Note: The notes are secured.

    Published on 12/8/2014
  • BTG completes placing

    BTG plc (LSE:BTG), London, U.K. Business: Neurology, Cardiovascular, Cancer Date completed: 2014-12-04 Type: Placing Raised: 150 million ($234.6 million) Shares: 18.9 million Price: 795p Shares after offering: 381.7 …

    Published on 12/8/2014
  • Canbridge completes venture financing

    Canbridge Life Sciences Ltd., Beijing, China Business: Cancer Date completed: 2014-12-02 Type: Venture financing Raised: $10 million Investors: Qiming Venture Partners; TF Capital

    Published on 12/8/2014
  • CARsgen completes venture financing

    CARsgen, Shanghai, China Business: Cancer Date completed: 2014-11-26 Type: Venture financing Raised: Not disclosed Investor: BVCF Note: The amount raised is not disclosed.

    Published on 12/8/2014
  • Cell Medica completes venture financing

    Cell Medica Ltd., London, U.K. Business: Gene/Cell therapy, Infectious Date completed: 2014-11-25 Type: Venture financing Raised: 50 million ($78.2 million) Investors: Imperial Innovations Group plc; Invesco; Woodford …

    Published on 12/8/2014
  • Critical Outcome Technologies completes private placement of units

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer, Autoimmune, Infectious Date completed: 2014-11-26 Type: Private placement of units Raised: $702,420 Units: 3.1 million Price…

    Published on 12/8/2014
  • Eleven Biotherapeutics completes debt financing

    Eleven Biotherapeutics Inc. (NASDAQ:EBIO), Cambridge, Mass. Business: Ophthalmic Date completed: 2014-11-26 Type: Debt financing Raised: $10 million Investor: Silicon Valley Bank Note: Eleven drew down $10 million under…

    Published on 12/8/2014
  • Eleven Biotherapeutics completes private placement of common stock and warrants

    Eleven Biotherapeutics Inc. (NASDAQ:EBIO), Cambridge, Mass. Business: Ophthalmic Date completed: 2014-11-25 Type: Private placement of common stock and warrants Raised: $20 million Shares: 1.7 million Price: $11.47 …

    Published on 12/8/2014
  • Fennec Pharmaceuticals completes private placement of units

    Fennec Pharmaceuticals Inc. (TSX:FRX; OTCQB:FENCF), Research Triangle Park, N.C. Business: Cancer, Other Date completed: 2014-12-03 Type: Private placement of units Raised: $2.2 million Units: 732,266 Price: $3 (unit) …

    Published on 12/8/2014
  • Flamel completes private placement

    Flamel Technologies S.A. (NASDAQ:FLML), Lyon, France Business: Drug delivery Date completed: 2014-12-02 Type: Private placement Raised: $13 million Shares: 1 million Price: $12.71 (ADS) Shares after offering: 40 million…

    Published on 12/8/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993